Overcoming MDR by ultrasound-induced hyperthermia and P-glycoprotein modulation

Biochemical and Biophysical Research Communications

Volumn 289, Issue 1, 2001, Pages 62-68

  Liu, Yang ^a,b   Lillehei, Kevin ^b   Cobb, Wesley N ^c   Christians, Uwe ^b   Ng, Ka Yun ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF DENVER   (United States)

Author keywords

Cancer; Doxorubicin; Efflux; Hyperthermia; MDR; Multidrug resistance; P glycoprotein; Rhodamine 123; Ultrasound; Uptake

Indexed keywords

DOXORUBICIN; GLYCOPROTEIN P; RHODAMINE 123; VALSPODAR;

ARTICLE; CYTOTOXICITY; DRUG EFFECT; DRUG RELEASE; HUMAN; HUMAN CELL; HYPERTHERMIC THERAPY; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; TREATMENT OUTCOME; ULTRASOUND;

EID: 0035941040     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2001.5938     Document Type: Article

References (20)

1. Multidrug resistance: Molecular mechanisms and clinical relevance
2. Biochemistry of multidrug resistance mediated by the multidrug transporter
3. Biochemical, cellular, and pharmacological aspects of the multidrug transporter
4. Modulation and prevention of multidrug resistance by inhibitors of P- glycoprotein
5. A phase I trial of doxorubicin, paclitaxel, and valspodar (PSC 833), a modulator of multidrug resistance
6. Phase I/II trial of the multidrug-resistance modulator valspodar combined with cisplatin and doxorubicin in refractory ovarian cancer
7. Phase I/II study of the P-glycoprotein modulator PSC 833 in patients with acute myeloid leukemia
8. Combined action of PSC 833 (Valspodar), a novel MDR reversing agent, with mitoxantrone, etoposide and cytarabine in poor-prognosis acute myeloid leukemia
9. High intensity focused ultrasound for benign prostatic hyperplasia
10. Long-term outcome of transrectal high-intensity focused ultrasound therapy for benign prostatic hyperplasia
11. The current and potential role of hyperthermia in radiotherapy
12. For the clinical application of thermochemotherapy given at mild temperatures
13. Ultrasound-induced hyperthermia increases cellular uptake and cytotoxicity of P-glycoprotein substrates in multidrug resistant cells
14. Efficacy of MGI 114 (6-hydroxy-methylacylfulvene, HMAF) against the mdr1/gp170 metastatic MV522 lung carcinoma xenograft
15. Multiple drug-resistant human KB carcinoma cells independently selected for high-level resistance to colchicine, adriamycin, or vinblastine show changes in expression of specific proteins
16. Cytotoxic activity of cyclosporin A
17. The multidrug resistance modulator SDZ PSC 833 is a potent activator of cellular ceramide formation
18. A reexamination of PSC 833 (Valspodar) as a cytotoxic agent and in combination with anticancer agents
19. Analysis of the interactions of SDZ PSC 833 ([3′-keto-Bmt1]-Val2]-Cyclosporine), a multidrug resistance modulator, with P-glycoprotein